Skip to main content

Table 1 Baseline demographics, behavioral out

From: Efficacy of the ‘Stand and Move at Work’ multicomponent workplace intervention to reduce sedentary time and improve cardiometabolic risk: a group randomized clinical trial

 

Stand+

Move+

Total

n (%)

n (%)

n (%)

N worksites

12 (50.0)

12 (50.0)

24 (100.0)

N individuals

354 (56.2)

276 (43.8)

630 (100.0)

Region

 Phoenix, Arizona

194 (54.8)

138 (50.0)

332 (52.7)

 Minneapolis/St. Paul, Minnesota

160 (45.2)

138 (50.0)

298 (47.3)

 Age (years)

45.6 ± 11.4

43.3 ± 10.8

44.6 ± 11.2

Race

 Non-Hispanic White

239 (67.5)

205 (74.3)

444 (70.5)

 Hispanic

57 (16.1)

30 (10.9)

87 (13.8)

 Non-Hispanic Black

20 (5.7)

6 (2.2)

26 (4.1)

 Non-Hispanic Asian

15 (4.2)

17 (6.2)

32 (5.1)

 Other/Multiracial/Unknown

23 (6.5)

18 (6.5)

41 (6.5)

 Female

296 (83.6)

173 (62.7)

469 (74.4)

Education

 Less than college

14 (4.0)

15 (5.4)

29 (4.6)

 College/Some college

234 (66.1)

151 (54.7)

385 (61.1)

 Graduate/Professional

93 (26.3)

98 (35.5)

191 (30.3)

 Unknown

13 (3.7)

12 (4.4)

25 (4.0)

Work sector

 Academic

119 (33.6)

94 (34.1)

213 (33.8)

 Industry/healthcare

123 (34.8)

83 (30.1)

206 (32.7)

 Government

112 (31.6)

99 (35.9)

211 (33.5)

Job type

 Executive

43 (12.2)

39 (14.1)

82 (13.0)

 Professional

182 (51.4)

155 (56.2)

337 (53.5)

 Clerical

120 (33.9)

72 (26.1)

192 (30.5)

Behavioral Outcomes

 Work periods (min per 8 h workday)

  Sitting

330.8 ± 79.8

337.9 ± 73.1

334.0 ± 76.9

  Standing

113.6 ± 75.9

104.3 ± 69.8

109.5 ± 73.4

  LPA

29.9 ± 14.0

31.4 ± 15.4

30.5 ± 14.6

  MVPA

5.7 ± 4.7

6.4 ± 5.3

6.0 ± 5.0

  LPA + MVPA

35.6 ± 15.4

37.8 ± 17.2

36.6 ± 16.2

  Prolonged sitting (> 30 min)

142.3 ± 90.5

161.8 ± 85.7

150.9 ± 88.9

  Sit-stand transitions (n/sitting-hr)

7.8 ± 5.8

6.1 ± 6.6

7.0 ± 6.2

 Total time (min per day)

  Sitting

619.8 ± 95.0

624.9 ± 87.4

622.1 ± 91.7

  Standing

243.1 ± 82.9

236.4 ± 75.4

240.2 ± 79.7

  LPA

79.5 ± 27.7

80.4 ± 28.3

79.9 ± 27.9

  MVPA

17.7 ± 7.6

18.2 ± 7.2

17.9 ± 7.4

  LPA + MVPA

97.1 ± 31.4

98.6 ± 31.9

97.8 ± 31.6

  Prolonged sitting (> 30 min)

308.3 ± 107.2

322.5 ± 103.0

314.6 ± 105.5

  Sit-stand transitions (n/sitting-hr)

6.0 ± 2.2

5.4 ± 1.9

5.7 ± 2.1

Cardiometabolic risk biomarkers

 CMR (sum of Z scores)

0.02 ± 0.7

−0.01 ± 0.6

0.00 ± 0.7

 Fasting glucose (mg/dL)

96.5 ± 37.1

91.0 ± 14.1

94.1 ± 29.4

 Fasting insulin (uU/mL)

77.6 ± 57.3

71.1 ± 55.0

74.7 ± 56.3

 HDL-cholesterol (mg/dL)

60.1 ± 18.8

56.4 ± 16.5

58.5 ± 17.9

 Triglycerides (mg/dL)

121.0 ± 74.4

120.3 ± 68.1

120.7 ± 71.7

 Diastolic BP (mm Hg)

77.7 ± 10.7

77.4 ± 10.7

77.5 ± 10.7

 Systolic BP (mm Hg)

124.9 ± 16.4

123.4 ± 15.7

124.3 ± 16.1

 LDL-cholesterol (mg/dL)

110.8 ± 30.3

113.1 ± 34.1

111.8 ± 32.0

 Weight (kg)

82.2 ± 22.8

82.9 ± 20.8

82.5 ± 21.9

 BMI (kg/m2)

29.8 ± 7.6

28.7 ± 6.4

29.3 ± 7.1

 Total body fat (%)

36.3 ± 9.6

32.8 ± 10.2

34.7 ± 10.0

  1. CMR summary continuous metabolic risk score, HDL High-density lipoprotein, BP Blood pressure, BMI Body mass index